210 related articles for article (PubMed ID: 8377686)
1. Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
Hockings BE; Ireland MA; Gotch-Martin KF; Taylor RR
Med J Aust; 1993 Sep; 159(6):376-8. PubMed ID: 8377686
[TBL] [Abstract][Full Text] [Related]
2. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ
N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and prevention of aortocoronary bypass graft occlusion.
Chesebro JH; Fuster V
Int J Clin Pharmacol Res; 1986; 6(4):261-7. PubMed ID: 3531036
[TBL] [Abstract][Full Text] [Related]
4. [Permeability of aortocoronary bypass after 6 months. A multicenter French study].
Ollivier JP
Arch Mal Coeur Vaiss; 1991 Apr; 84(4):537-42. PubMed ID: 2064515
[TBL] [Abstract][Full Text] [Related]
5. Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
Circulation; 1990 Nov; 82(5 Suppl):IV237-42. PubMed ID: 2225410
[TBL] [Abstract][Full Text] [Related]
6. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
[TBL] [Abstract][Full Text] [Related]
7. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
[TBL] [Abstract][Full Text] [Related]
8. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
Chesebro JH; Clements IP; Fuster V; Elveback LR; Smith HC; Bardsley WT; Frye RL; Holmes DR; Vlietstra RE; Pluth JR; Wallace RB; Puga FJ; Orszulak TA; Piehler JM; Schaff HV; Danielson GK
N Engl J Med; 1982 Jul; 307(2):73-8. PubMed ID: 7045659
[TBL] [Abstract][Full Text] [Related]
9. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.
Bourassa MG; Fisher LD; Campeau L; Gillespie MJ; McConney M; Lespérance J
Circulation; 1985 Dec; 72(6 Pt 2):V71-8. PubMed ID: 3905060
[TBL] [Abstract][Full Text] [Related]
10. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts.
Kohler TR; Kaufman JL; Kacoyanis G; Clowes A; Donaldson MC; Kelly E; Skillman J; Couch NP; Whittemore AD; Mannick JA
Surgery; 1984 Sep; 96(3):462-6. PubMed ID: 6474351
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).
Cataldo G; Braga M; Pirotta N; Lavezzari M; Rovelli F; Marubini E
Circulation; 1993 Nov; 88(5 Pt 2):II93-8. PubMed ID: 8222202
[TBL] [Abstract][Full Text] [Related]
12. The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
Rosenthal D; Mittenthal MJ; Ruben DM; Jones DH; Estes JW; Stanton PE; Lamis PA
Am Surg; 1987 Sep; 53(9):477-81. PubMed ID: 3631756
[TBL] [Abstract][Full Text] [Related]
13. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts.
McEnany MT; Salzman EW; Mundth ED; DeSanctis RW; Harthorne JW; Weintraub RM; Gates S; Austen WG
J Thorac Cardiovasc Surg; 1982 Jan; 83(1):81-9. PubMed ID: 7033673
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of anticoagulant management after coronary artery bypass surgery--warfarin versus dipyridamole].
Yamaguchi A; Kitamura N; Miki T; Tatebayashi T; Kawashima M; Otaki M; Tamura H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Apr; 40(4):485-9. PubMed ID: 1613273
[TBL] [Abstract][Full Text] [Related]
15. Influence of vein graft use on postoperative 1-year results after off-pump coronary artery bypass surgery.
Cho KR; Jeong DS; Kim KB
Eur J Cardiothorac Surg; 2007 Nov; 32(5):718-23. PubMed ID: 17822913
[TBL] [Abstract][Full Text] [Related]
16. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries.
Lytle BW; Loop FD; Taylor PC; Goormastic M; Stewart RW; Novoa R; McCarthy P; Cosgrove DM
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):605-12; discussion 612-4. PubMed ID: 8468995
[TBL] [Abstract][Full Text] [Related]
17. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.
Yilmaz MB; Balbay Y; Caldir V; Ayaz S; Guray Y; Guray U; Korkmaz S
Thromb Res; 2005; 115(1-2):25-9. PubMed ID: 15567449
[TBL] [Abstract][Full Text] [Related]
18. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. Etude de la Ticlopidine après Pontage Fémoro-Poplité and the Association Universitaire de Recherche en Chirurgie.
Becquemin JP
N Engl J Med; 1997 Dec; 337(24):1726-31. PubMed ID: 9392698
[TBL] [Abstract][Full Text] [Related]
19. Saphenous vein graft disease treated with the Wiktor Hepamed stent: procedural outcome, in-hospital complications and six-month angiographic follow-up.
Van Langenhove G; Vermeersch P; Serrano P; Kutryk MJ; Stockman D; Convens C; Van den Branden F; Vanagt E; Albertal M; Van den Heuvel P
Can J Cardiol; 2000 Apr; 16(4):473-80. PubMed ID: 10787462
[TBL] [Abstract][Full Text] [Related]
20. [Factors which affect long-term patency in femoro-popliteal bypass].
Marković DM; Davidović LB; Lotina SI; Kostić DM; Colić M; Pejkić SU; Jakovljević NS; Djorić P
Srp Arh Celok Lek; 2000; 128(1-2):17-23. PubMed ID: 10916459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
